Major Endocrine and Targeted Therapy Advances In the Treatment of HR+/HER2- Breast Cancer
Vicente Valero, MD, FACP
Molecular Classification in Endometrial Cancer: A Real-World Approach to Staging and Treatment
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
Prostate and Bladder Cancers: What Have we Learned Over the Past Year?
Chandler H. Park, MD, MSc, FACP
Will Biosimilars Reduce Financial Toxicity of Cancer Therapy
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Antibody Drug Conjugates for HER2 Negative Breast Cancer: Advancing Breast Cancer Management
Suchita Pakkala, MD
